• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

多重耐药鲍曼不动杆菌爆发：医疗机构中的全球性问题。

Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings.

机构信息

Universidade Federal da Grande Dourados, Laboratório de Pesquisa em Ciências da Saúde, Dourados, MS, Brasil.

出版信息

Rev Soc Bras Med Trop. 2020 Nov 6;53:e20200248. doi: 10.1590/0037-8682-0248-2020. eCollection 2020.

DOI:10.1590/0037-8682-0248-2020
PMID:33174956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7670754/
Abstract

INTRODUCTION

The increase in the prevalence of multidrug-resistant Acinetobacter baumannii infections in hospital settings has rapidly emerged worldwide as a serious health problem.

METHODS

This review synthetizes the epidemiology of multidrug-resistant A. baumannii, highlighting resistance mechanisms.

CONCLUSIONS

Understanding the genetic mechanisms of resistance as well as the associated risk factors is critical to develop and implement adequate measures to control and prevent acquisition of nosocomial infections, especially in an intensive care unit setting.

摘要

简介

多药耐药鲍曼不动杆菌感染在医院环境中的流行率迅速上升，已成为全球严重的健康问题。

方法

本综述综合了多药耐药鲍曼不动杆菌的流行病学情况，重点介绍了耐药机制。

结论

了解耐药的遗传机制以及相关的危险因素对于制定和实施适当的措施来控制和预防医院获得性感染至关重要，尤其是在重症监护病房环境中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90f/7670754/552361c6fc4d/1678-9849-rsbmt-53-e20200248-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90f/7670754/552361c6fc4d/1678-9849-rsbmt-53-e20200248-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d90f/7670754/552361c6fc4d/1678-9849-rsbmt-53-e20200248-gf1.jpg

相似文献

1
Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings.多重耐药鲍曼不动杆菌爆发：医疗机构中的全球性问题。
Rev Soc Bras Med Trop. 2020 Nov 6;53:e20200248. doi: 10.1590/0037-8682-0248-2020. eCollection 2020.
2
Molecular epidemiology of multidrug-resistant clinical isolates of Acinetobacter baumannii : A 10-year analysis in a large tertiary care university hospital in central Europe with international admissions.多药耐药临床分离鲍曼不动杆菌的分子流行病学：中欧一家大型三级教学医院的 10 年分析，包括国际收治患者。
Wien Klin Wochenschr. 2017 Nov;129(21-22):816-822. doi: 10.1007/s00508-017-1242-7. Epub 2017 Aug 3.
3
Frequency And Clinical Spectrum Of Multidrug Resistant Acinetobacter Baumannii As A Significant Nosocomial Pathogen In Intensive Care Unit Patients.多重耐药鲍曼不动杆菌作为 ICU 患者重要医院感染病原菌的频率及临床谱。
J Ayub Med Coll Abbottabad. 2021 Oct-Dec;33(Suppl 1)(4):S752-S756.
4
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.多重耐药鲍曼不动杆菌感染的药物治疗
Future Microbiol. 2008 Dec;3(6):649-60. doi: 10.2217/17460913.3.6.649.
5
Acinetobacter baumannii: an emerging multidrug-resistant threat.鲍曼不动杆菌：一种新出现的多重耐药威胁。
Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309.
6
Longitudinal epidemiology of multidrug-resistant (MDR) Acinetobacter species in a tertiary care hospital.多药耐药（MDR）不动杆菌属在一家三级医院的纵向流行病学研究。
Am J Infect Control. 2012 Mar;40(2):134-7. doi: 10.1016/j.ajic.2011.04.326. Epub 2011 Aug 11.
7
Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.全球耐药鲍曼不动杆菌的传播：抗菌药物耐药性的分子流行病学和管理。
Future Microbiol. 2011 Apr;6(4):407-22. doi: 10.2217/fmb.11.23.
8
The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.多重耐药不动杆菌属的出现：医院环境中的一个主要问题。
Lett Appl Microbiol. 2005;41(5):375-8. doi: 10.1111/j.1472-765X.2005.01791.x.
9
Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii.多药耐药鲍曼不动杆菌的遗传学、流行病学和临床表现。
J Hosp Infect. 2020 Jan;104(1):4-11. doi: 10.1016/j.jhin.2019.09.021. Epub 2019 Oct 4.
10
Multidrug-resistant infections: looming threat in the Indian clinical setting.多重耐药感染：印度临床环境中迫在眉睫的威胁。
Expert Rev Anti Infect Ther. 2022 May;20(5):721-732. doi: 10.1080/14787210.2022.2016393. Epub 2021 Dec 27.

引用本文的文献

1
Potential of Cannabidiol (CBD) to overcome extensively drug-resistant Acinetobacter baumannii.大麻二酚（CBD）克服广泛耐药鲍曼不动杆菌的潜力。
BMC Complement Med Ther. 2025 Aug 15;25(1):308. doi: 10.1186/s12906-025-05056-w.
2
Prevalence and antimicrobial resistance of in the livestock industry in South Korea under a One Health perspective.在“同一健康”视角下韩国畜牧业中[具体内容缺失]的流行情况及抗菌药物耐药性
One Health. 2025 May 11;20:101071. doi: 10.1016/j.onehlt.2025.101071. eCollection 2025 Jun.
3
Analyzing Clinical Parameters and Bacterial Profiles to Uncover the COPD Exacerbations: A Focus on Intensive Care Unit Challenges.

本文引用的文献

1
Comparative Genomics of Clinical Strains From Brazil Reveals Polyclonal Dissemination and Selective Exchange of Mobile Genetic Elements Associated With Resistance Genes.巴西临床菌株的比较基因组学揭示了多克隆传播以及与抗性基因相关的移动遗传元件的选择性交换。
Front Microbiol. 2020 Jun 17;11:1176. doi: 10.3389/fmicb.2020.01176. eCollection 2020.
2
Investigation of carbapenemases and aminoglycoside modifying enzymes of Acinetobacter baumannii isolates recovered from patients admitted to intensive care units in a tertiary-care hospital in Brazil.巴西一家三级医院重症监护病房患者分离的鲍曼不动杆菌碳青霉烯酶和氨基糖苷修饰酶研究。
Rev Soc Bras Med Trop. 2019 Dec 20;53:e20190044. doi: 10.1590/0037-8682-0094-2019. eCollection 2019.
3
分析临床参数和细菌谱以揭示慢性阻塞性肺疾病急性加重：聚焦重症监护病房的挑战
Medicina (Kaunas). 2025 Apr 5;61(4):669. doi: 10.3390/medicina61040669.
4
Whole-genome evaluation and prophages characterization associated with genome of carbapenem-resistant Acinetobacter baumannii UOL-KIMZ-24-2.与耐碳青霉烯鲍曼不动杆菌UOL-KIMZ-24-2基因组相关的全基因组评估和原噬菌体特征分析
Curr Genet. 2025 Jan 24;71(1):4. doi: 10.1007/s00294-024-01307-4.
5
Environmental contamination with carbapenem resistant in healthcare settings in Fiji: a potential source of infection.斐济医疗机构中碳青霉烯类耐药菌的环境污染：潜在的感染源。
Front Cell Infect Microbiol. 2024 Sep 23;14:1429443. doi: 10.3389/fcimb.2024.1429443. eCollection 2024.
6
Phytochemical Composition and Antimicrobial and Antibiofilm Effect of Hydroethanolic Extract against and .水乙醇提取物对[具体对象1]和[具体对象2]的植物化学成分、抗菌及抗生物膜作用
Methods Protoc. 2024 Aug 4;7(4):60. doi: 10.3390/mps7040060.
7
Genomic Landscape Reveals Chromosomally-Mediated Antimicrobial Resistome and Virulome of a High-Risk International Clone II AB073 from Thailand.基因组景观揭示了来自泰国的高风险国际克隆 II AB073 的染色体介导的抗微生物组和毒力组。
Glob Health Epidemiol Genom. 2024 Apr 30;2024:8872463. doi: 10.1155/2024/8872463. eCollection 2024.
8
A comparative study of genotyping and antimicrobial resistance between carbapenem-resistant and isolates at a tertiary pediatric hospital in China.中国一家三级儿科医院耐碳青霉烯肠杆菌科细菌与非耐碳青霉烯肠杆菌科细菌的基因型和抗菌药物耐药性比较研究。
Front Cell Infect Microbiol. 2024 Mar 8;14:1298202. doi: 10.3389/fcimb.2024.1298202. eCollection 2024.
9
Deciphering the structure of a multi-drug resistant Acinetobacter baumannii short-chain dehydrogenase reductase.解析多药耐药鲍曼不动杆菌短链脱氢酶还原酶的结构。
PLoS One. 2024 Feb 23;19(2):e0297751. doi: 10.1371/journal.pone.0297751. eCollection 2024.
10
Molecular and clinical epidemiology of carbapenem resistant ST2 in Oceania: a multicountry cohort study.大洋洲耐碳青霉烯类 ST2 的分子与临床流行病学：一项多国队列研究
Lancet Reg Health West Pac. 2023 Sep 22;40:100896. doi: 10.1016/j.lanwpc.2023.100896. eCollection 2023 Nov.
Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii.多药耐药鲍曼不动杆菌的遗传学、流行病学和临床表现。
J Hosp Infect. 2020 Jan;104(1):4-11. doi: 10.1016/j.jhin.2019.09.021. Epub 2019 Oct 4.
4
A systematic review of the global seasonality of infections caused by Acinetobacter species in hospitalized patients.一项关于住院患者中由不动杆菌属引起的感染的全球季节性的系统评价。
Clin Microbiol Infect. 2020 May;26(5):553-562. doi: 10.1016/j.cmi.2019.09.020. Epub 2019 Oct 3.
5
Molecular characterization of clinical and environmental carbapenem resistant Acinetobacter baumannii isolates in a hospital of the Eastern Region of Saudi Arabia.沙特阿拉伯东部地区一家医院临床和环境中产碳青霉烯酶鲍曼不动杆菌分离株的分子特征。
J Infect Public Health. 2020 Apr;13(4):632-636. doi: 10.1016/j.jiph.2019.08.013. Epub 2019 Sep 21.
6
Plasmid-mediated mcr-1 gene in Acinetobacter baumannii and Pseudomonas aeruginosa: first report from Pakistan.质粒介导的鲍曼不动杆菌和铜绿假单胞菌 mcr-1 基因：来自巴基斯坦的首次报告。
Rev Soc Bras Med Trop. 2019 Sep 5;52:e20190237. doi: 10.1590/0037-8682-0237-2019.
7
Mechanisms of Polymyxin Resistance.多粘菌素耐药机制。
Adv Exp Med Biol. 2019;1145:55-71. doi: 10.1007/978-3-030-16373-0_5.
8
Control of outbreak in the neonatal intensive care unit in Latvia: whole-genome sequencing powered investigation and closure of the ward.拉脱维亚新生儿重症监护病房暴发疫情的控制：全基因组测序助力调查和关闭病房。
Antimicrob Resist Infect Control. 2019 May 22;8:84. doi: 10.1186/s13756-019-0537-z. eCollection 2019.
9
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.多重耐药鲍曼不动杆菌血症的获得及死亡危险因素：来自一家中国医院的回顾性研究
Medicine (Baltimore). 2019 Mar;98(13):e14937. doi: 10.1097/MD.0000000000014937.
10
Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates.分析临床分离株中 GyrA 和 ParC 的喹诺酮类药物耐药决定区的突变模式。
Int J Antimicrob Agents. 2019 Mar;53(3):318-324. doi: 10.1016/j.ijantimicag.2018.12.004. Epub 2018 Dec 21.